サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1414523

プロトンポンプ阻害剤の世界市場レポート 2024年

Proton Pump Inhibitors Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
プロトンポンプ阻害剤の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

プロトンポンプ阻害剤の市場規模は近年着実に成長しています。2023年の33億米ドルから2024年にはCAGR4.5％で34億4,000万米ドルに成長します。過去数年間に見られた成長は、胃食道逆流症（GERD）の流行、消化性潰瘍疾患の発生率、高齢化人口の増加、ライフスタイルや食習慣の変化、認知度の向上や診断方法の改善など、いくつかの要因によるものです。これらの要因が相まって、GERDや消化性潰瘍など胃酸に関連する疾患に対処するために一般的に使用されるプロトンポンプ阻害剤（PPI）などの医薬品市場が拡大しています。慢性疾患の増加は、人口動態や社会の変化と相まって、酸関連疾患の管理を目的とした治療に対する需要を形成する上で重要な役割を果たしています。

プロトンポンプ阻害剤市場規模は、今後数年で安定した成長が見込まれます。2028年にはCAGR4.6％で41億2,000万米ドルに成長すると予測されます。予測期間の成長は、新興市場でのプロトンポンプ阻害剤（PPI）の採用、ヘリコバクター・ピロリ感染の有病率の増加、患者教育に重点を置いた取り組み、戦略的なマーケティングおよびプロモーション活動に起因すると考えられます。予測期間に予想される世界の動向には、PPIとデジタルヘルスソリューションの統合、世界市場の拡大、胃腸の健康に関する教育への関心の高まり、規制措置と安全プロトコルの更新、これらの薬剤の環境への影響への配慮などが含まれます。これらの要因は総体的に、PPIの使用状況や市場力学の進化に寄与しており、予測される期間において医学的および環境的考察の両方に対処するための多面的なアプローチを反映しています。

プロトンポンプ阻害剤市場の成長は、胃腸障害の有病率の増加によって牽引されると予測されます。胃腸障害には、吐き気、嘔吐、食中毒、下痢など、胃腸（GI）管に影響を及ぼすさまざまな症状が含まれます。プロトンポンプ阻害剤（PPI）は、胃酸の分泌を抑えることにより、胸やけや酸関連疾患の管理に重要な役割を果たしています。胃腸疾患の罹患率が上昇していることは、2022年に胃がん罹患者が2,572人に達すると予測されているCancerAustraliaなどの団体の統計からも明らかであり、これらの健康課題に対処するためのPPIの需要が強調されています。さらに、米国消化器病学会（American Gastroenterological Association）の洞察によると、過去1年間にアメリカ人の40%以上が重度の胃腸症状によって日常生活を制限していることが明らかになっています。このような個人の生活への大きな影響は、プロトンポンプ阻害剤のような効果的な治療法の必要性をさらに強調しています。

ヘリコバクター・ピロリ感染の増加は、プロトンポンプ阻害薬市場の成長に寄与すると予想されています。ヘリコバクター・ピロリ菌は、小腸上部と胃粘膜に影響を及ぼす細菌感染症です。PPIは一般的にピロリ菌感染症の治療計画の一部として処方され、抗生物質と併用されることが多いです。Best Practice Advocacy Centre New Zealandが強調しているように、ピロリ菌感染症の世界の流行は、世界の50％以上の人々が感染しており、アフリカ、アジア、ラテンアメリカではより高い感染率であることから、この細菌感染症に対処するプロトンポンプ阻害剤のような効果的な治療法の必要性が広く強調されています。胃腸障害とピロリ菌感染という二重の影響により、PPIが一般的な健康問題に対処し、市場成長を促進する上で重要な役割を果たしていることが強調されています。

2023年のプロトンポンプ阻害剤市場で最大の地域は北米でした。アジア太平洋は、予測期間中にプロトンポンプ阻害剤の世界市場規模において最も急成長する地域となる見込みです。プロトンポンプ阻害剤市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のプロトンポンプ阻害剤市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • パントプラゾール
  • オメプラゾール
  • ランソプラゾール
  • エソメプラゾール
  • ラベプラゾール
  • デクスランソプラゾール
  • その他のタイプ
  • 世界のプロトンポンプ阻害剤市場、疾患別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 潰瘍
  • 胃食道逆流症
  • その他の疾患適応症
  • 世界のプロトンポンプ阻害剤市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 診療所
  • その他の用途

第7章 地域および国の分析

  • 世界のプロトンポンプ阻害剤市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のプロトンポンプ阻害剤市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • プロトンポンプ阻害剤市場の競合情勢
  • プロトンポンプ阻害剤市場の企業プロファイル
    • AstraZeneca plc
    • Pfizer Inc.
    • Cadila Pharmaceuticals Limited
    • Eisai Pharmaceuticals India Pvt. Ltd
    • Wyeth LLC

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r12033

“Proton Pump Inhibitors Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on proton pump inhibitors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for proton pump inhibitors? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The proton pump inhibitors market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Pantoprazole; Omeprazole; Lansoprazole; Esomeprazole; Rabeprazole; Dexlansoprazole; Other Types
  • 2) By Disease Allocation: Ulcers; Gastroesophageal Reflux Disease; Other Disease Indications
  • 3) By Application: Hospitals; Clinic; Other Applications
  • Companies Mentioned: AstraZeneca plc; Pfizer Inc.; Cadila Pharmaceuticals Limited; Eisai Pharmaceuticals India Pvt. Ltd; Wyeth LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Proton pump inhibitors (PPIs) constitute a category of medications designed to diminish the production of stomach acid. They find application in addressing conditions arising from either an excessive production of stomach acid or conditions aggravated by such acidity, including acid reflux and stomach ulcers.

The primary types of proton pump inhibitors encompass pantoprazole, omeprazole, lansoprazole, esomeprazole, rabeprazole, dexlansoprazole, and other derivatives. Pantoprazole, belonging to the proton pump inhibitor class, operates by reducing the volume of acid generated by the stomach. These medications play a crucial role in the treatment of ulcers, gastroesophageal reflux disease (GERD), and other related conditions. The usage of proton pump inhibitors is widespread in various healthcare settings, including hospitals, clinics, and other treatment centers, where they contribute significantly to managing acid-related disorders.

The proton pump inhibitors market research report is one of a series of new reports from The Business Research Company that provides proton pump inhibitors market statistics, including proton pump inhibitors industry global market size, regional shares, competitors with a proton pump inhibitors market share, detailed proton pump inhibitors market segments, market trends, and opportunities, and any further data you may need to thrive in the proton pump inhibitors industry. This proton pump inhibitors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The proton pump inhibitors market size has grown steadily in recent years. It will grow from $3.3 billion in 2023 to $3.44 billion in 2024 at a compound annual growth rate (CAGR) of 4.5%. The growth observed in the historical period can be attributed to several factors, including the prevalence of gastroesophageal reflux disease (GERD), the incidence of peptic ulcer disease, a growing aging population, shifts in lifestyles and dietary habits, as well as an increase in awareness and improved diagnostic practices. These factors collectively contributed to the expanding market for medications, such as proton pump inhibitors (PPIs), which are commonly used to address conditions associated with stomach acid, such as GERD and peptic ulcers. The rise in chronic conditions, coupled with demographic and societal changes, has played a significant role in shaping the demand for treatments aimed at managing acid-related disorders.

The proton pump inhibitors market size is expected to see steady growth in the next few years. It will grow to $4.12 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%.The anticipated growth in the forecast period can be attributed to the adoption of proton pump inhibitors (PPIs) in emerging markets, an increase in the prevalence of Helicobacter pylori infections, initiatives focused on patient education, and strategic marketing and promotional activities. Significant trends expected in the forecast period encompass the integration of PPIs with digital health solutions, the expansion of the global market, a heightened focus on education related to gastrointestinal health, updates in regulatory measures and safety protocols, and considerations for the environmental impact of these medications. These factors collectively contribute to the evolving landscape of PPI usage and market dynamics, reflecting a multifaceted approach to address both medical and environmental considerations in the forecasted period.

The growth of the proton pump inhibitors market is anticipated to be driven by the increasing prevalence of gastrointestinal disorders. Gastrointestinal disorders encompass a range of conditions affecting the gastrointestinal (GI) tract, including nausea, vomiting, food poisoning, and diarrhea. Proton pump inhibitors (PPIs) play a crucial role in managing heartburn and acid-related disorders by reducing the production of stomach acid. The rising incidence of gastrointestinal disorders, as evidenced by statistics from organizations such as Cancer Australia, where stomach cancer cases are projected to reach 2,572 in 2022, underscores the demand for PPIs in addressing these health challenges. Additionally, insights from the American Gastroenterological Association reveal that severe gastrointestinal symptoms have led over 40% of Americans to curtail daily activities in the past year. This substantial impact on individuals' lives further emphasizes the need for effective treatments such as proton pump inhibitors.

The increased occurrence of Helicobacter pylori infections is expected to contribute to the growth of the proton pump inhibitor market. Helicobacter pylori is a bacterial infection affecting the upper part of the small intestine and the stomach lining. PPIs are commonly prescribed as part of treatment plans for H. pylori infections, often in combination with antibiotics. The global prevalence of H. pylori infections, highlighted by the Best Practice Advocacy Centre New Zealand, with over 50% of people worldwide infected and higher rates in Africa, Asia, and Latin America, emphasizes the widespread need for effective therapies such as proton pump inhibitors to address this bacterial infection. This dual influence of gastrointestinal disorders and H. pylori infections underscores the significant role PPIs play in addressing prevalent health issues and driving market growth.

Product innovation is a prominent trend gaining momentum in the proton pump inhibitors market, with major companies strategically focusing on the development of innovative products to enhance their market position and gain a competitive edge. A notable example is Xiromed LLC, the US-based generic division of Insud Pharmaceuticals, which launched Omeprazole Delayed-Release Capsules, 20mg, in March 2021. This generic version of Prilosec is designed to treat symptoms associated with gastroesophageal reflux disease (GERD) and conditions caused by excess stomach acid. Omeprazole, a proton pump inhibitor, effectively addresses gastric acid-related disorders such as GERD and peptic ulcer disease.

Companies in the proton pump inhibitor market are also directing their efforts towards obtaining approvals for innovative products. One such instance is the U.S. Food and Drug Administration (FDA) approval of KONVOMEP, an oral suspension containing omeprazole and sodium bicarbonate. This product aims to treat active benign gastric ulcers and reduce the risk of upper gastrointestinal bleeding in critically ill patients. KONVOMEP, being a liquid mixture of sodium bicarbonate and the proton pump inhibitor omeprazole, is particularly beneficial for individuals who have difficulty swallowing tablets or capsules. Azurity Pharmaceuticals, Inc., a US-based pharmaceutical company, secured FDA approval for Konvomep in September 2022, addressing the need for liquid medication options, especially for those with difficulty swallowing solid oral doses.

In July 2022, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical company, acquired the Abbreviated New Drug Application (ANDA) for famotidine tablets from Wockhardt, marking a strategic move in expanding its presence in the American over-the-counter (OTC) market. The acquired ANDA includes famotidine tablets, cetirizine hydrochloride tablets, lansoprazole delayed-release capsules, and olopatadine hydrochloride ophthalmic solution. This acquisition reflects Glenmark's commitment to ensuring patient access to high-quality and affordable medications.

Major companies operating in the proton pump inhibitors market report are AstraZeneca plc, Pfizer Inc., Cadila Pharmaceuticals Limited, Eisai Pharmaceuticals India Pvt. Ltd., Wyeth LLC, Eli Lilly and Company, Bayer AG, Takeda Pharmaceutical Company, Santarus Inc., Janssen Pharmaceuticals, GlaxoSmithKline plc, Changzhou Siyao Pharmaceuticals, Yangzhou Pharmaceutical, Sanofi S.A., Johnson & Johnson, Novartis International AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Cipla Limited, Hetero Drugs Limited, Intas Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Micro Labs Ltd., Natco Pharma Limited, Panacea Biotec Ltd., Strides Pharma Science Limited, Wockhardt Ltd.

North America was the largest region in the proton pump inhibitors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global proton pump inhibitors market size during the forecast period. The regions covered in the proton pump inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the proton pump inhibitors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The proton pump inhibitors market consists of sales of pantoprazole, and lansoprazole DR. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Proton Pump Inhibitors Market Characteristics

3. Proton Pump Inhibitors Market Trends And Strategies

4. Proton Pump Inhibitors Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Proton Pump Inhibitors Market Size and Growth

  • 5.1. Global Proton Pump Inhibitors Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Proton Pump Inhibitors Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Proton Pump Inhibitors Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Proton Pump Inhibitors Market Segmentation

  • 6.1. Global Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pantoprazole
  • Omeprazole
  • Lansoprazole
  • Esomeprazole
  • Rabeprazole
  • Dexlansoprazole
  • Other Types
  • 6.2. Global Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Ulcers
  • Gastroesophageal Reflux Disease
  • Other Disease Indications
  • 6.3. Global Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinic
  • Other Applications

7. Proton Pump Inhibitors Market Regional And Country Analysis

  • 7.1. Global Proton Pump Inhibitors Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Proton Pump Inhibitors Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Proton Pump Inhibitors Market

  • 8.1. Asia-Pacific Proton Pump Inhibitors Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Proton Pump Inhibitors Market

  • 9.1. China Proton Pump Inhibitors Market Overview
  • 9.2. China Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Proton Pump Inhibitors Market

  • 10.1. India Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Proton Pump Inhibitors Market

  • 11.1. Japan Proton Pump Inhibitors Market Overview
  • 11.2. Japan Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Proton Pump Inhibitors Market

  • 12.1. Australia Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Proton Pump Inhibitors Market

  • 13.1. Indonesia Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Proton Pump Inhibitors Market

  • 14.1. South Korea Proton Pump Inhibitors Market Overview
  • 14.2. South Korea Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Proton Pump Inhibitors Market

  • 15.1. Western Europe Proton Pump Inhibitors Market Overview
  • 15.2. Western Europe Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Proton Pump Inhibitors Market

  • 16.1. UK Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Proton Pump Inhibitors Market

  • 17.1. Germany Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Proton Pump Inhibitors Market

  • 18.1. France Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Proton Pump Inhibitors Market

  • 19.1. Italy Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Proton Pump Inhibitors Market

  • 20.1. Spain Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Proton Pump Inhibitors Market

  • 21.1. Eastern Europe Proton Pump Inhibitors Market Overview
  • 21.2. Eastern Europe Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Proton Pump Inhibitors Market

  • 22.1. Russia Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Proton Pump Inhibitors Market

  • 23.1. North America Proton Pump Inhibitors Market Overview
  • 23.2. North America Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Proton Pump Inhibitors Market

  • 24.1. USA Proton Pump Inhibitors Market Overview
  • 24.2. USA Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Proton Pump Inhibitors Market

  • 25.1. Canada Proton Pump Inhibitors Market Overview
  • 25.2. Canada Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Proton Pump Inhibitors Market

  • 26.1. South America Proton Pump Inhibitors Market Overview
  • 26.2. South America Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Proton Pump Inhibitors Market

  • 27.1. Brazil Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Proton Pump Inhibitors Market

  • 28.1. Middle East Proton Pump Inhibitors Market Overview
  • 28.2. Middle East Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Proton Pump Inhibitors Market

  • 29.1. Africa Proton Pump Inhibitors Market Overview
  • 29.2. Africa Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Proton Pump Inhibitors Market Competitive Landscape And Company Profiles

  • 30.1. Proton Pump Inhibitors Market Competitive Landscape
  • 30.2. Proton Pump Inhibitors Market Company Profiles
    • 30.2.1. AstraZeneca plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Pfizer Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Cadila Pharmaceuticals Limited
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Eisai Pharmaceuticals India Pvt. Ltd
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Wyeth LLC
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Proton Pump Inhibitors Market Competitive Benchmarking

32. Global Proton Pump Inhibitors Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Proton Pump Inhibitors Market

34. Proton Pump Inhibitors Market Future Outlook and Potential Analysis

  • 34.1 Proton Pump Inhibitors Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Proton Pump Inhibitors Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Proton Pump Inhibitors Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer